Interaction of [d-Trp⁶, Des-Gly¹⁰] LHRH Ethylamide and Hydroxy Propyl β-Cyclodextrin (HPβCD): Thermodynamics of Interaction and Protection from Degradation by α-Chymotrypsin

REFERENCES

• Vale W., Rivier C., Brown M., Rivier J. I. McIntyreClinical Endocrinology, . 5th Suppl, Blackwell Scientific Publications, Oxford 1976
   Google Scholar
• Fraser H.M., Baird D.T. Clinical Applications of LHRH Analogues. Baillieres Clin. Endocrinol. Metab. 1987; 1: 43–70
   PubMedGoogle Scholar
• Nicholson R.I., Walker K.J. Influence of LHRH Agoinists in the Growth and Hormonal Environments of Breast and Prostate Cancer. Chemioterapia 1987; 4(3)249–251
   Google Scholar
• Kompella U.B., Dani B.A. Metabolism of [Des-Gly10, d-Trp6] LHRH Ethylamide in Rabbit Nasal Tissue. Life Sci. 1996; 58(24)2201–2207
   PubMedGoogle Scholar
• Kompella U.B., Dani B.A. Metabolism of [Des-Gly10, d-Trp6] LHRH Ethylamide in the Rabbit Conjunctiva. J. Occul. Pharmacol. Therap. 1997; 13(2)163–170
   PubMedGoogle Scholar
• Brewster M.E., Simpkins J.E., Hora M.S., Stern W.C., Bodor N. The Potential Use of Cyclodextrins in Parenteral Formulations. J. Parenteral Sci. Technol. 1989; 43(5)231–240
   PubMedGoogle Scholar
• Ozkan Y., Atay T., Dikmen N., Isimer A., Aboul-Enein H.Y. Improvement of Water Solubility and In Vitro Dissolution Rate of Gliclazide by Complexation with Beta-Cyclodextrin. Pharm. Acta. Helv. 2000; 74(4)365–370
   PubMedGoogle Scholar
• Yamamoto M., Hirayama F., Uekama K. Improvement of Stability and Dissolution of Prostaglandin E1 by Maltosyl-Beta-Cyclodextrin in Lyophilized Formulation. Chem. Pharm. Bull. (Tokyo) 1992; 40(3)747–751
   PubMedGoogle Scholar
• Lin S.Z., Wouessidjewe D., Poelman M.C., Duchene D. Indomethacin and Cyclodextrin Complexes. Int. J. Pharm. 1991; 69: 211–219
   Web of Science ®Google Scholar
• Tokihiro K., Irie T., Uekama K., Pitha J. Pharm. Sci. 1995; 1: 49
   Google Scholar
• Cooper A. Effect of Cyclodextrins on the Thermal Stability of Globular Proteins. J. Am. Chem. Soc. 1992; 114: 9208–9209
   Web of Science ®Google Scholar
• Matsubara K., Irie T., Uekama K. Spectroscopic Characterization of the Inclusion Complex of a Leutinizing Hormone Releasing Hormone Agonist, Buserelin Acetate, with Dimethyl-β-Cyclodextrin. Chem. Pharm. Bull. 1997; 45: 378–381
   PubMedGoogle Scholar
• Irie T., Wakamatsu K., Arima H., Aritomi H., Uekama K. Enhancing Effects of Cyclodextrins on Nasal Absorption of Insulin in Rats. Int. J. Pharm. 1992; 84: 129–139
   Web of Science ®Google Scholar
• Matsubara K., Irie T., Uekama K., Abe K. Improvement of Nasal Bioavailability of Leutinizing Hormone Releasing Hormone Agonist, Buselerin, by Cyclodextrin Derivatives in Rats. J. Pharm. Sci. 1995; 84(11)1295–1300
   PubMed Web of Science ®Google Scholar
• Pitha J., Pitha J. Amorphous Water-Soluble Derivatives of Cyclodextrins: Nontoxic Dissolution Enhancing Excipients. J. Pharm. Sci. 1985; 74(9)987–990
   PubMed Web of Science ®Google Scholar
• Uekama K., Otagiri M. Cyclodextrins in Drug Carrier Systems. CRC Crit. Rev. Therap. Drug Carrier Syst. 1987; 3: 1–40
   PubMed Web of Science ®Google Scholar
• Perczel A., Fasman G.D. Quantitative Analysis of Cyclic β-Turn Models. Protein Sci. 1992; 1: 378–395
   PubMedGoogle Scholar
• Manning M.C. Conformation of the Alpha Form of Human Calcitonin Gene-Related Peptide (CGRP) in Aqueous Solution as Determined by Circular Dichroism Spectroscopy. Biochem. Biophys. Res. Commun. 1989; 160: 388–392
   PubMedGoogle Scholar
• Smitz J., Devroey P., Camus M., Deschacht J., van Waesberghe L., Wisanto A., van Steirteghem A.C. Inhibition of Gonadotropic and Ovarian Function by Intranasal Administration of d-Ser (TBU) 6-EA 10 LHRH in Normo-Ovulatory Women and Patients with Polycystic Ovary Disease. J. Endocrinol. Invest. 1988; 11(9)647–652
   PubMedGoogle Scholar
• Wilding I.R., Davis S.S., O'Hagan D.T. Targeting of Drugs and Vaccines to the Gut. Pharmacol. Ther. 1994; 62: 97
   PubMed Web of Science ®Google Scholar
• Okada H., Heya T., Ogawa Y., Shimamoto T. One-Month Release Injectable Microcapsules of a Leutinizing Hormone Releasing Hormone Agonist (Leuprolide Acetate) for Treating Experimental Endometriosis in Rats. J. Pharmacol. Exp. Ther. 1988; 244(2)744–750
   PubMed Web of Science ®Google Scholar
• Hussain M.A., Aungst B.J. Nasal Mucosal Metabolism of an LH RH Fragment and Inhibition with Boroleucine. Int. J. Pharm. 1994; 105: 7–10
   Web of Science ®Google Scholar
• Raehs S.C., Sandow J., Wiirth K., Merkle H.P. The Adjuvant Effect of Bacitracin on Nasal Absorption of Gonadarelin and Buserelin in Rats. Pharm. Res. 1988; 5: 689–693
   PubMed Web of Science ®Google Scholar
• Adjei A., Sundberg D., Miller J., Chun A. Bioavailability of Leuprolide Acetate Following Nasal and Inhalation Delivery to Rats and Healthy Humans. Pharm. Res. 1992; 9(2)244–249
   PubMedGoogle Scholar
• Watanabe Y., Matsumoto Y., Kawamoto K., Yazawa S., Matasumoto M. Enhancing Effects of Cyclodextrin on Nasal Absorption of Insulin and its Duration in Rabbits. Chem. Pharm. Bull. 1992; 40(11)3100–3104
   PubMedGoogle Scholar
• Cantor C.R., Schimmel P.R. Cantor, SchimmelBiophysical Chemistry Part II Techniques for the Study of Biological Structure and Function, . W.H. Freeman and Company, New York 1980; 349 pp
   Google Scholar
• Lakowicz J.R. Principles of Fluorescence Spectroscopy. Plenum Press, New York 1983
   Google Scholar
• Chattopadhyay A., Mukherjee S. Red Edge Excitation Shift of a Deeply Embedded Membrane Probe: Implications in Water Penetration in the Bilayer. J. Phys. Chem. 1999; 103: 8180–8185
   Google Scholar
• Orstan A., Ross J.B.A. Investigation of the β-Cyclodextrin–Indole Inclusion Complex by Absorption and Fluorescence Spectroscopies. J. Phys. Chem. 1987; 91: 2739–2745
   Web of Science ®Google Scholar
• Manning C.M., Illangaseke M., Woody R.W. Circular Dichroism Studies of Distorted Alpha-Helices, Twisted Beta-Sheets and Beta Turns. Biophys. Chem. 1988; 31(1–2)77–86
   PubMedGoogle Scholar
• Powers M.E., Adjei A., Fu Lu M.Y., Manning M.C. Solution behavior of leuprolide acetate, an LHRH agonist, as determined by circular dichroism spectroscopy. Int. J. Pharm. 1994; 108: 49–55
   Google Scholar
• Marche P., Garestier T.M., Helene C., Fromageot P. Conformational Characteristics of Luliberin. Circular Dichroism and Fluorescence Studies. Biochemistry 1976; 15(26)5730–5737
   PubMedGoogle Scholar
• Goodman M., Naider F., Toniolo C. Circular Dichroism Studies of Isoleucine Oligopeptides in Solution. Biopolymers 1971; 10: 1719–1730
   PubMedGoogle Scholar
• Woody R.W. E.R. Blout, F.A. Bovey, M. Goodman, N. LotanPeptides, Polypeptides and Proteins, . John Wiley and Sons, New York 1974; 338 pp
   Google Scholar
• Kauzman W. Some Factors in the Interpretation of Protein Denaturation. Adv. Protein Chem. 1959; 14: 1
   PubMedGoogle Scholar
• Tanford C. The Hydrophobic Effect: Formation of Micelles and Biological Membranes. 2nd Ed, Marcel Dekker, New York 1980
   Google Scholar
• Hess G.P. P.D. BoyerChymotrypsin—Chemical Properties and Catalysis, . Academic Press, New York 1993; Vol. III: 213–248
   Google Scholar
• Matsubara K., Ando Y., Irie T., Uekama K. Protection Afforded by Maltosyl-Beta-Cyclodextrin Against α-Chymotrypsin Catalyzed Hydrolysis of a Leutinizing Hormone Releasing Hormone Agonist, Buserelin Acetate. Pharm. Res. 1997; 14(10)1401–1405
   PubMedGoogle Scholar